418
Q. Sha, Y. Wei
PAPER
GC-MS (EI, 70 eV): m/z = 341.9.
4-Bromo-3-methyl-5-(2-nitrophenyl)-3-phenyl-3H-pyrazole
(3ah)
Anal. Calcd for C17H15BrN2O (342.04): C, 59.49; H, 4.41; N, 8.16.
Found: C, 59.56; H, 4.43; N, 8.09.
Gray solid; yield: 85.7 mg (80%); mp 133–136 °C; Rf = 0.19 (PE–
EtOAc, 10:1).
4-Bromo-3-methyl-5-(4-nitrophenyl)-3-phenyl-3H-pyrazole
1H NMR (500 MHz, CDCl3): δ = 8.23–8.21 (m, 1 H), 7.80–7.77 (m,
1 H), 7.75–7.73 (m, 1 H), 7.70–7.67 (m, 1 H), 7.44–7.38 (m, 3 H),
7.31–7.27 (m, 2 H), 1.92 (s, 3 H).
13C NMR (125 MHz, CDCl3): δ = 149.64, 148.61, 140.38, 133.58,
132.40, 132.17, 130.78, 129.25, 129.07, 126.45, 125.37, 125.25,
100.43, 19.26.
(3ac)
Yellow solid; yield: 89.9 mg (84%); mp 154–157 °C; Rf = 0.34
(PE–EtOAc, 10:1).
1H NMR (500 MHz, CDCl3): δ = 8.56 (d, J = 8.5 Hz, 2 H), 8.37 (d,
J = 8.5 Hz, 2 H), 7.40–7.37 (m, 3 H), 7.19–7.17 (m, 2 H), 1.91 (s, 3
H).
GC-MS (EI, 70 eV): m/z = 356.9.
13C NMR (125 MHz, CDCl3): δ = 148.00, 147.47, 141.04, 135.84,
132.31, 129.18, 129.08, 128.81, 126.17, 123.99, 101.88, 19.76.
Anal. Calcd for C16H12BrN3O2 (357.01): C, 53.65; H, 3.38; N,
11.73. Found: C, 53.58; H, 3.39; N, 11.80.
GC-MS (EI, 70 eV): m/z = 356.8.
4-Bromo-3-(4-methoxyphenyl)-3-methyl-5-phenyl-3H-pyr-
azole (3ba)
Yellow liquid; yield: 83.1 mg (81%); Rf = 0.40 (PE–EtOAc, 10:1).
Anal. Calcd for C16H12BrN3O2 (357.01): C, 53.65; H, 3.38; N,
11.73. Found: C, 54.54; H, 3.46; N, 11.82.
4-Bromo-5-(4-chlorophenyl)-3-methyl-3-phenyl-3H-pyrazole
(3ad)
1H NMR (500 MHz, CDCl3): δ = 8.39 (d, J = 7 Hz, 2 H), 7.55 (t,
J = 7.5 Hz, 2 H), 7.50 (t, J = 7 Hz, 1 H), 7.14 (d, J = 8.5 Hz, 2 H),
6.91 (d, J = 9 Hz, 2 H), 3.81 (s, 3 H), 1.88 (s, 3 H).
13C NMR (125 MHz, CDCl3): δ = 159.85, 149.16, 136.98, 129.84,
129.68, 128.77, 128.03, 127.56, 114.38, 100.52, 55.34, 19.76.
Yellow liquid; yield: 85.1 mg (82%); Rf = 0.62 (PE–EtOAc, 10:1).
1H NMR (500 MHz, CDCl3): δ = 8.34–8.33 (m, 2 H), 7.53–7.53 (m,
2 H), 7.39–7.37 (m, 3 H), 7.22–7.20 (m, 2 H), 1.90 (s, 3 H).
13C NMR (125 MHz, CDCl3): δ = 148.45, 137.12, 135.66, 132.82,
129.32, 129.20, 129.05, 128.84, 128.25, 126.22, 101.10, 19.72.
GC-MS (EI, 70 eV): m/z = 341.8.
Anal. Calcd for C17H15BrN2O (342.04): C, 59.49; H, 4.41; N, 8.16.
Found: C, 59.53; H, 4.46; N, 8.11.
GC-MS (EI, 70 eV): m/z = 345.8.
Anal. Calcd for C16H12BrClN2 (345.99): C, 55.28; H, 3.48; N, 8.06.
Found: C, 55.41; H, 3.45; N, 7.93.
4-Bromo-3-ethyl-3,5-diphenyl-3H-pyrazole (3ca)
Yellow solid; yield: 81.2 mg (83%); mp 50–53 °C; Rf = 0.55 (PE–
EtOAc, 10:1).
1H NMR (500 MHz, CDCl3): δ = 8.40–8.38 (m, 2 H), 7.58–7.55 (m,
2 H), 7.53–7.50 (m, 1 H), 7.39–7.36 (m, 3 H), 7.32–7.30 (m, 2 H),
3.01–2.94 (m, 1 H), 2.37–2.30 (m, 1 H), 0.71 (t, J = 7.5 Hz, 3 H).
13C NMR (125 MHz, CDCl3): δ = 150.55, 134.92, 133.63, 129.89,
129.79, 129.07, 128.86, 128.73, 128.21, 126.64, 104.22, 27.48,
7.50.
4-Bromo-3-methyl-3-phenyl-5-(2-pyridyl)-3H-pyrazole (3ae)
Brown liquid; yield: 70.4 mg (75%); Rf = 0.22 (PE–EtOAc, 10:1).
1H NMR (500 MHz, CDCl3): δ = 8.84–8.82 (m, 1 H), 8.41 (d, J = 8
Hz, 1 H), 7.91–7.88 (m, 1 H), 7.42–7.34 (m, 4 H), 7.23–7.21 (m, 2
H), 1.91 (s, 3 H).
13C NMR (125 MHz, CDCl3): δ = 149.94, 149.26, 149.20, 141.23,
137.15, 132.72, 129.12, 128.93, 126.41, 124.13, 123.94, 101.40,
19.81.
GC-MS (EI, 70 eV): m/z = 325.9.
GC-MS (EI, 70 eV): m/z = 312.8.
Anal. Calcd for C17H15BrN2 (326.04): C, 62.40; H, 4.62; N, 8.56.
Found: C, 62.56; H, 4.54; N, 8.49.
Anal. Calcd for C15H12BrN3 (313.02): C, 57.34; H, 3.85; N, 13.37.
Found: C, 57.44; H, 3.91; N, 13.33.
4-(4-Bromo-3-methyl-5-phenyl-3H-pyrazol-3-yl)benzonitrile
(3da)
4-Bromo-5-(2-furyl)-3-methyl-3-phenyl-3H-pyrazole (3af)
Brown liquid; yield: 77.9 mg (86%); Rf = 0.55 (PE–EtOAc, 10:1).
1H NMR (500 MHz, CDCl3): δ = 7.68–7.67 (m, 1 H), 7.39–7.33 (m,
4 H), 7.23–7.20 (m, 2 H), 6.64–6.63 (m, 1 H), 1.88 (s, 3 H).
13C NMR (125 MHz, CDCl3): δ = 145.82, 144.20, 143.52, 133.06,
Yellow solid; yield: 73.8 mg (73%); mp 45–47 °C; Rf = 0.22 (PE–
EtOAc, 10:1).
1H NMR (500 MHz, CDCl3): δ = 8.37–8.34 (m, 2 H), 7.68–7.67 (m,
2 H), 7.55–7.51 (m, 3 H), 7.35–7.33 (m, 2 H), 1.90 (s, 3 H).
13C NMR (125 MHz, CDCl3): δ = 150.43, 138.50, 135.14, 12.86,
130.20, 129.36, 128.98, 128.20, 127.31, 118.37, 112.37, 100.25,
19.90.
132.27, 129.00, 128.76, 126.28, 112.74, 111.86, 100.51, 19.91.
GC-MS (EI, 70 eV): m/z = 301.8.
Anal. Calcd for C14H11BrN2O (302.01): C, 55.47; H, 3.66; N, 9.24.
Found: C, 55.53; H, 3.71; N, 9.27.
GC-MS (EI, 70 eV): m/z = 336.8.
Anal. Calcd for C17H12BrN3 (337.02): C, 60.37; H, 3.58; N, 12.42.
Found: C, 60.46; H, 3.62; N, 12.33.
4-Bromo-3-methyl-3-phenyl-5-(2-thienyl)-3H-pyrazole (3ag)
Gray solid; yield: 77.3 mg (81%); mp 115–117 °C; Rf = 0.54 (PE–
EtOAc, 10:1).
1H NMR (500 MHz, CDCl3): δ = 8.20 (d, J = 3.5 Hz, 1 H), 7.58–
7.56 (m, 1 H), 7.40–7.36 (m, 3 H), 7.27–7.23 (m, 3 H), 1.91 (s, 3 H).
13C NMR (125 MHz, CDCl3): δ = 146.47, 133.37, 132.33, 129.11,
4-Bromo-3,5-diphenyl-1H-pyrazole (5ea)
White solid; yield: 67.9 mg (76%); mp 207–208 °C (Lit.14 199–200
°C, Lit.15 195 °C); Rf = 0.38 (PE–EtOAc, 3:1).
1H NMR (500 MHz, CDCl3): δ = 7.79–7.78 (m, 4 H), 7.45–7.41 (m,
6 H), 5.16 (s, 1 H).
1H NMR (500 MHz, DMSO-d6): δ = 13.75 (s, 1 H), 7.85–7.76 (m,
4 H), 7.55–7.41 (m, 6 H).
128.86, 128.23, 127.92, 126.39, 100.89, 20.11.
GC-MS (EI, 70 eV): m/z = 317.8.
13C NMR (125 MHz, CDCl3): δ = 146.45, 129.39, 129.12, 128.63,
128.01, 91.74.
Anal. Calcd for C14H11BrN2S (317.98): C, 52.68; H, 3.47; N, 8.78.
Found: C, 52.59; H, 3.55; N, 8.91.
13C NMR (125 MHz, DMSO-d6): δ = 149.43, 141.53, 133.01,
129.54, 129.40, 128.96, 128.83, 128.63, 128.12.
Synthesis 2013, 45, 413–420
© Georg Thieme Verlag Stuttgart · New York